Mucinous rectal adenocarcinoma and neoadjuvant therapy: Implications for surgical practice

doi:10.4240/wjgs.v18.i5.115825

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 5

This Article

(21)

(25)

(0)

(33)

(460)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Surg. May 27, 2026; 18(5): 115825
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.115825

Table 4 Postoperative outcomes and recurrence patterns in mucinous rectal tumors

Ref.	Outcome	MAC	Non-MAC
Hugen et al[2], 2014; McCawley et al[23], 2016	3-year local recurrence rate (%)	14-26	4-8
Hugen et al[2], 2014; Lan et al[7], 2021	3-year disease-free survival (%)	58-64	76-82
Hugen et al[2], 2014; Lan et al[7], 2021	Common metastatic sites	Peritoneum, lung	Liver
McCawley et al[23], 2016; Hugen et al[2], 2014	Median time to recurrence (months)	13-16	18-21
Hugen et al[2], 2014	Recurrence with peritoneal carcinomatosis (%)	20-28	< 10

MAC: Mucinous adenocarcinoma.

Full Size Table

Citation: Patriti A, Graziano F, Chiari R. Mucinous rectal adenocarcinoma and neoadjuvant therapy: Implications for surgical practice. World J Gastrointest Surg 2026; 18(5): 115825
URL: https://www.wjgnet.com/1948-9366/full/v18/i5/115825.htm
DOI: https://dx.doi.org/10.4240/wjgs.v18.i5.115825

Patriti A, Graziano F, Chiari R. Mucinous rectal adenocarcinoma and neoadjuvant therapy: Implications for surgical practice. World J Gastrointest Surg 2026; 18(5): 115825 [DOI: 10.4240/wjgs.v18.i5.115825]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.